When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

Rocky Mountain MS Clinic opened a location in Lehi this week, filling a gap in care for patients who have traveled hours or ...

Multiple sclerosis is a disease that affects the central nervous system, according to the Mayo Clinic's website. The immune system attacks the myelin, or protective sheath, that covers nerve fibers.

Multiple sclerosis sufferer Braylee Burnett, who turns 18 on Wednesday, learned she can once again resume infusions for her ...